Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CDKN2A |
Variant | L65fs |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | CDKN2A L65fs results in a change in the amino acid sequence of the Cdkn2a protein beginning at aa 65 of 156, likely resulting in premature truncation of the functional protein (UniProt.org). L65fs has not been characterized, however, due to the effects of other truncation mutations downstream of L65 (PMID: 9053859, PMID: 8668202), is predicted to lead to a loss of Cdkn2a protein function. |
Associated Drug Resistance | |
Category Variants Paths |
CDKN2A mutant CDKN2A inact mut CDKN2A L65fs |
Transcript | NM_000077.5 |
gDNA | chr9:g.(21971166_21971167) |
cDNA | c.(193_192) |
Protein | p.L65fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_011517676.2 | chr9:g.(21971166_21971167) | c.(193_192) | p.L65fs | RefSeq | GRCh38/hg38 |
NM_000077 | chr9:g.(21971166_21971167) | c.(193_192) | p.L65fs | RefSeq | GRCh38/hg38 |
NM_000077.5 | chr9:g.(21971166_21971167) | c.(193_192) | p.L65fs | RefSeq | GRCh38/hg38 |
NM_058197 | chr9:g.(21974635_21974636) | c.(193_192) | p.L65fs | RefSeq | GRCh38/hg38 |
XM_011517676 | chr9:g.(21971166_21971167) | c.(193_192) | p.L65fs | RefSeq | GRCh38/hg38 |
NM_058197.5 | chr9:g.(21974635_21974636) | c.(193_192) | p.L65fs | RefSeq | GRCh38/hg38 |
NM_001195132.1 | chr9:g.(21971166_21971167) | c.(193_192) | p.L65fs | RefSeq | GRCh38/hg38 |
XM_011517675 | chr9:g.(21971166_21971167) | c.(193_192) | p.L65fs | RefSeq | GRCh38/hg38 |
NM_000077.4 | chr9:g.(21971166_21971167) | c.(193_192) | p.L65fs | RefSeq | GRCh38/hg38 |
XM_011517675.3 | chr9:g.(21971166_21971167) | c.(193_192) | p.L65fs | RefSeq | GRCh38/hg38 |
XM_011517675.2 | chr9:g.(21971166_21971167) | c.(193_192) | p.L65fs | RefSeq | GRCh38/hg38 |
NM_058197.4 | chr9:g.(21974635_21974636) | c.(193_192) | p.L65fs | RefSeq | GRCh38/hg38 |
NM_001195132 | chr9:g.(21971166_21971167) | c.(193_192) | p.L65fs | RefSeq | GRCh38/hg38 |
XM_011517676.3 | chr9:g.(21971166_21971167) | c.(193_192) | p.L65fs | RefSeq | GRCh38/hg38 |
NM_001195132.2 | chr9:g.(21971166_21971167) | c.(193_192) | p.L65fs | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|